Page 94 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 94

5









                                            The Major Histocompatibility Complex



                                                                         Dimitrios S. Monos, Robert J. Winchester







           A  primary  objective  of  the  immune system  is  to  protect  our   GENOMIC ORGANIZATION OF THE MHC
           bodies against pathogens. The major histocompatibility complex
           (MHC) comprises a genomic region that has evolved to include   The human MHC region includes approximately 3.8 million
           many genes responsible for coordinating the immune response.   base pairs (Mbps) of DNA on the short arm of chromosome
           It is named the histocompatibility complex because it was first   6 (6p21.3) and is defined as the region spanning from the
           identified as the site of numerous genes that determined whether   gamma-aminobutyric acid receptor (GABBR1) gene on the
           transplanted tissue would be accepted or rejected. We now know   telomeric side of the region to the kinesin family member C1
           that this region coordinates immunological functions far beyond   (KIFC1) gene toward the centromere (ENSEMBL 86 GRCh38.
                                                                                                    1
           those related to histocompatibility. The MHC region includes   p7 coordinates chr6: 29555629-33409924).  More recent work
           genes that determine both innate and adaptive immunities and   has  suggested  that  the  functional  MHC  region  may include
           thus influences responses to pathogens (viruses, bacteria, fungi,   additional downstream and upstream sequences totaling seven
           and parasites), transplantation, autoimmunity, cancer biology,   or more Mbps.
           vaccinations, responses to drugs, and possibly other functionalities   The classic 3.8Mbp MHC region is among the most gene-dense
           presently unknown. This chapter describes some aspects of the   segments of the human genome. It includes 158 protein-coding
           genomic organization of the MHC region and its immunological   genes and 86 pseudogenes of unknown functionality (ENSEMBL
                                                                               2
           importance, focusing primarily on the human leukocyte antigen   86  GRCh38.p7).   At  least  65  (41%)  of the  coding  genes  are
                                                                                                     2
           (HLA) genes and their encoded molecules. These HLA molecules   involved in innate and adaptive immunities.  The MHC is one
           play a central role in adaptive immunity. They serve as the   of the most studied regions of the genome because it includes
           structures that present self and foreign peptides to T cells (Chapter   the genes that encode the highly polymorphic HLA proteins,
           6). They also participate in aspects of innate immunity by   which play a pivotal role in immune recognition. The MHC is
           interacting with receptors on the surface of natural killer (NK)   divided into three regions: class I, class II, and class III (Fig. 5.1).
           cells (Chapter 17). The terms HLA and MHC are often used   The class I region is at the telomeric end and includes the classic
           interchangeably. However, in this chapter, “MHC” is reserved   HLA class I genes (HLA-A, HLA-B, and HLA-C), the class I–related
           for the broader genomic region, and “HLA” is used to indicate   (like) genes (MICA, MICB), the nonclassic HLA class I genes
           the genes and their respective encoded protein products in   (HLA-E, HLA-F, and HLA-G), and four pseudogenes (HLA-H,
           humans.                                                HLA-K, HLA-J, and HLA-L). The class II region occupies the
                                                                  centromeric  end  and  contains  the  DRA  and  DRB1  genes
                                                                  and, depending on the DR haplotype, one or none of the
                                                                  DRB3, DRB4, DRB5 genes that code for the DR, DR52, DR53,
                                                                  or DR51 molecules, respectively; the DQA1 and DQB1 genes
               CLINICAL RELEVANCE                                 that encode the DQ molecule; and the DPA1 and DPB1 genes
                                                                  that encode the DP molecule. It also includes the DM and DO
            •  HLA molecules regulate antigen-specific immune responses by binding   genes encoding the antigen-processing molecules DM and DO
              pathogen-derived peptides and then presenting them to either CD4
              or CD8 T cells.                                     involved in the class II antigen presentation pathway (Chapter
              •  CD4 T cells activated by MHC class II peptide complexes can   6), as well as the TAP and LMP genes encoding proteins involved
                stimulate B cells to produce antigen-specific antibodies.  in the classic class I antigen presentation pathway (Chapter 6).
              •  CD8 T cells activated by MHC class I peptide complexes become   The class III region, interposed between class I and II regions,
                cytotoxic and can kill the cells that present the pathogen-derived   is a very gene-dense region and contains many immune and
                peptides.                                         non-immune  related genes, including  those  encoding  some
            •  Certain HLA alleles are the major genetic determinants of susceptibility
              to many autoimmune diseases or drug hypersensitivity reactions.  complement components, lymphotoxin α and β, tumor necrosis
              •  The process involves a combination of self peptides or small   factor (TNF), heat shock proteins (HSPs), NFKB, NOTCH4, and
                molecules (drugs) bound to specific HLA alleles and then recognized   21-hydroxylase (CYP21). The genes within the HLA class I and
                by T-cell receptors.                              class II regions demonstrate the sequence and structural homology
            •  HLA molecules play a key role in governing transplant rejection and   that marks evolution through mechanisms of gene conversion,
              appear to regulate placental development in pregnancy.  gene duplications, insertions, deletions, and subsequent mutations,
            •  Cancerous cells modify expression of their HLA genes to avoid recogni-
              tion by the immune response.                        resulting in divergence of function.  Although the genomic
                                                                  organization of class I and class II genes is quite distinct, the

                                                                                                                  79
   89   90   91   92   93   94   95   96   97   98   99